Tim Mills , PhD

Partner
Business Development
Sanderling Ventures
Menlo Park, CA

TIMOTHY MILLS joined Sanderling as an Operating Partner in July, 1998 with over fifteen years of experience in biomedical research and corporate management. Prior to joining Sanderling, Dr. Mills served as the Corporate Vice President of New Business Development and Chief Scientific Officer of Target Therapeutics, a medical device company that was acquired by Boston Scientific for $1.2 billion in 1997. He also served as the Director for Prograft Medical, a Target affiliate.